astragaloside a has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, PC; Lai, GX; Lin, XH; Liu, DL; Wang, Q; Ye, J; Zhang, HW; Zhang, L | 1 |
Jia, L; Lv, D; Wang, Z; Zhang, S; Zhou, B | 1 |
Chen, XW; Dai, PC; He, CS; Jin, DH; Liu, YC; Xu, ZP | 1 |
3 other study(ies) available for astragaloside a and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6.
Topics: A549 Cells; Apoptosis; Astragalus propinquus; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Quinazolines; Saponins; Sirtuins; Triterpenes | 2017 |
Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway.
Topics: Apoptosis; beta Catenin; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Saponins; Signal Transduction; Triterpenes | 2019 |
Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3.
Topics: Apoptosis; B7 Antigens; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Cisplatin; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Saponins; Triterpenes | 2016 |